RTP startup backed by Eshelman hits clinical milestone
March 06, 2023 at 07:40 AM EST
A startup backed by one of North Carolina's most influential venture capitalists is moving its potential cancer treatment into a clinical study.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|